Physician

Linli Xuan, MD

According to 2025 Medicare claims, Linli Xuan, MD (NPI: 1609808831) practices hematology/oncology in the Olympia-Lacey-Tumwater, WA market, with the plurality of this provider's patient population coming from Thurston, WA. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 98502-4070. Xuan is affiliated with the PSW ACO (ACO ID: A5323), participating under the MSSP model.

Xuan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 683 traditional Medicare patients, billed 183,985 HCPCS/CPT codes, and received $2,998,716 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 984 prescription claims across 172 beneficiaries totaling $2,797,007 in drug costs, led by Imbruvica (Ibrutinib). 2022 DME data shows 43 claims. Open Payments data shows 110 records totaling $3,395. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,546,537 to $2,998,716. Similarly, Part D prescription costs have risen steadily, from $306,061 to $2,797,007. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $3,825 to $1,390.